West Valley City, Utah
Phase 1 cancer trials in West Valley City, UT
42 Phase 1 cancer studies are recruiting participants at sites in West Valley City as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
West Valley City at a glance
- 42 studies are recruiting at a site in West Valley City.
- By phase: Phase 1 (26), Phase 1/2 (16).
- By sponsor: industry (42).
- By research area: Breast Cancer (24), Lung Cancer (11), Lymphoma (3), Prostate Cancer (2), Melanoma (1), Pancreatic Cancer (1).
- Most recent update to one of these records: November 17, 2026.
Breast cancer studies recruiting in West Valley City
Basic details from each study's public record (the 30 most recently updated of 42). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Phase 1/2 Study of IAM1363 in HER2 Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Iambic Therapeutics, Inc
- Study site
- START Mountain Region
- Registry record
- NCT06253871 · updated
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- START Mountain Region
- Registry record
- NCT07488676 · updated
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pliant Therapeutics, Inc.
- Study site
- START Mountain Region
- Registry record
- NCT06270706 · updated
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Stemline Therapeutics, Inc.
- Study site
- START Mountain
- Registry record
- NCT06638307 · updated
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Study site
- START Mountain Region, LLC
- Registry record
- NCT07503808 · updated
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- NiKang Therapeutics, Inc.
- Study site
- South Texas Accelerated Research Therapeutics (START) Mountain Region
- Registry record
- NCT07029399 · updated
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study site
- START Mountain Region
- Registry record
- NCT07318805 · updated
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Genmab
- Study site
- START Mountain Region
- Registry record
- NCT05579366 · updated
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- START Mountain Region
- Registry record
- NCT06400472 · updated
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- START Mountain Region
- Registry record
- NCT06465069 · updated
A Study of MGC026 in Participants With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- MacroGenics
- Study site
- START Mountain Region
- Registry record
- NCT06242470 · updated
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Terremoto Biosciences Inc.
- Study site
- START Center for Cancer Research
- Registry record
- NCT07109726 · updated
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Cogent Biosciences, Inc.
- Study site
- START Mountain Region, LLC
- Registry record
- NCT07383506 · updated
A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Antares Therapeutics, Inc
- Study site
- START Mountain Region Cancer Center
- Registry record
- NCT07767474 · updated
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Olema Oncology, Inc.
- Study site
- START - Mountain Region
- Registry record
- NCT06784193 · updated
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Cogent Biosciences, Inc.
- Study site
- START Mountain Region
- Registry record
- NCT07361562 · updated
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
- Study site
- START Mountain Region
- Registry record
- NCT05985655 · updated
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Seagen, a wholly owned subsidiary of Pfizer
- Study site
- START Mountain Region
- Registry record
- NCT05208762 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in West Valley City, UT on ClinicalTrials.gov.
Lung cancer studies recruiting in West Valley City
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Study site
- START Mountain Region, LLC
- Registry record
- NCT07277413 · updated
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- TRIANA Biomedicines, Inc.
- Study site
- START-Mountain Region
- Registry record
- NCT07491497 · updated
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Sairopa B.V.
- Study site
- Start Center for Cancer Research - Mountain Region
- Registry record
- NCT05856981 · updated
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Gilead Sciences
- Study site
- START Mountain Region
- Registry record
- NCT06303505 · updated
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Phase 1/2
- Ages 18 to 75
- All sexes
- Sponsor
- Avenzo Therapeutics, Inc.
- Study site
- Avenzo Therapeutics Recruiting Site
- Registry record
- NCT07038343 · updated
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BioNTech SE
- Study site
- START Mountain Region
- Registry record
- NCT07070232 · updated
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- ALX Oncology Inc.
- Study site
- ALX Center 4
- Registry record
- NCT07085091 · updated
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Seagen, a wholly owned subsidiary of Pfizer
- Study site
- South Texas Accelerated Research Therapeutics Mountain Region
- Registry record
- NCT06131840 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in West Valley City, UT on ClinicalTrials.gov.
Prostate cancer studies recruiting in West Valley City
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
- Phase 1/2
- Ages 18 and older
- Male participants
- Sponsor
- GlaxoSmithKline
- Study site
- GSK Investigational Site
- Registry record
- NCT07332455 · updated
A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Janssen Research & Development, LLC
- Study site
- START Mountain Region
- Registry record
- NCT07746713 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in West Valley City, UT on ClinicalTrials.gov.
Melanoma studies recruiting in West Valley City
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- ModernaTX, Inc.
- Study site
- START Mountain Region
- Registry record
- NCT06880549 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in West Valley City, UT on ClinicalTrials.gov.
Lymphoma studies recruiting in West Valley City
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- Recursion Pharmaceuticals Inc.
- Study site
- START Mountain Region
- Registry record
- NCT06678659 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in West Valley City, UT on ClinicalTrials.gov.
Ask about studies near West Valley City
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Utah
All Utah locations
100 studies recruiting across 3 cities.
Salt Lake City
59 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections